<code id='54FE9DC547'></code><style id='54FE9DC547'></style>
    • <acronym id='54FE9DC547'></acronym>
      <center id='54FE9DC547'><center id='54FE9DC547'><tfoot id='54FE9DC547'></tfoot></center><abbr id='54FE9DC547'><dir id='54FE9DC547'><tfoot id='54FE9DC547'></tfoot><noframes id='54FE9DC547'>

    • <optgroup id='54FE9DC547'><strike id='54FE9DC547'><sup id='54FE9DC547'></sup></strike><code id='54FE9DC547'></code></optgroup>
        1. <b id='54FE9DC547'><label id='54FE9DC547'><select id='54FE9DC547'><dt id='54FE9DC547'><span id='54FE9DC547'></span></dt></select></label></b><u id='54FE9DC547'></u>
          <i id='54FE9DC547'><strike id='54FE9DC547'><tt id='54FE9DC547'><pre id='54FE9DC547'></pre></tt></strike></i>

          focus

          focus

          author:leisure time    Page View:3
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Faced with fears of OxyContin misuse, sales reps touted its safety
          Faced with fears of OxyContin misuse, sales reps touted its safety

          Photoillustration:STAT;photo:GettyImagesPIKEVILLE,Ky.—AyearandahalfaftertheopioidpainkillerOxyContin

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          TB outbreak tied to bone grafts underscores testing shortcomings

          WikimediaCommons/NIAIDOnepersonhasdiedandatleastfourhavebeensickenedbytuberculosisininfectedbonemate